SymBio Pharmaceuticals Limited and Eisai Co., Ltd. Conclude License Agreement for Bendamustine Hydrochloride (SyB L-0501

  Tokyo, May 18, 2009 - (JCN Newswire) - SymBio Pharmaceuticals Limited and Eisai Co., Ltd. announced today that the companies have concluded an exclusive license agreement on development and marketing for SyB L-0501 (bendamustine hydrochloride, & quot;Bendamustine & quot;). Under this agreement, SymBio shall grant exclusive development and marketing rights for Bendamustine to Eisai in both Korea and Singapore.  

Sydney

  [ Change ]
 
Today

Max: 17°
Rain at times.
Tomorrow

Min: 13°
Max: 18°
Rain.
 

Account

Login

To access your account and listings



Remember me
   
   
   
 
 
Find Hunter Valley accommodation online